Cargando…
Pro-senescence neddylation inhibitor combined with a senescence activated β-galactosidase prodrug to selectively target cancer cells
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458665/ https://www.ncbi.nlm.nih.gov/pubmed/36075909 http://dx.doi.org/10.1038/s41392-022-01128-2 |
| _version_ | 1784786339692019712 |
|---|---|
| author | Ni, Shuaishuai Liu, Qian Chen, Xin Ding, Lele Cai, Lili Mao, Fei Shi, Donglei Hoffman, Robert M. Li, Jian Jia, Lijun |
| author_facet | Ni, Shuaishuai Liu, Qian Chen, Xin Ding, Lele Cai, Lili Mao, Fei Shi, Donglei Hoffman, Robert M. Li, Jian Jia, Lijun |
| author_sort | Ni, Shuaishuai |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9458665 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94586652022-09-10 Pro-senescence neddylation inhibitor combined with a senescence activated β-galactosidase prodrug to selectively target cancer cells Ni, Shuaishuai Liu, Qian Chen, Xin Ding, Lele Cai, Lili Mao, Fei Shi, Donglei Hoffman, Robert M. Li, Jian Jia, Lijun Signal Transduct Target Ther Letter Nature Publishing Group UK 2022-09-09 /pmc/articles/PMC9458665/ /pubmed/36075909 http://dx.doi.org/10.1038/s41392-022-01128-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Ni, Shuaishuai Liu, Qian Chen, Xin Ding, Lele Cai, Lili Mao, Fei Shi, Donglei Hoffman, Robert M. Li, Jian Jia, Lijun Pro-senescence neddylation inhibitor combined with a senescence activated β-galactosidase prodrug to selectively target cancer cells |
| title | Pro-senescence neddylation inhibitor combined with a senescence activated β-galactosidase prodrug to selectively target cancer cells |
| title_full | Pro-senescence neddylation inhibitor combined with a senescence activated β-galactosidase prodrug to selectively target cancer cells |
| title_fullStr | Pro-senescence neddylation inhibitor combined with a senescence activated β-galactosidase prodrug to selectively target cancer cells |
| title_full_unstemmed | Pro-senescence neddylation inhibitor combined with a senescence activated β-galactosidase prodrug to selectively target cancer cells |
| title_short | Pro-senescence neddylation inhibitor combined with a senescence activated β-galactosidase prodrug to selectively target cancer cells |
| title_sort | pro-senescence neddylation inhibitor combined with a senescence activated β-galactosidase prodrug to selectively target cancer cells |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458665/ https://www.ncbi.nlm.nih.gov/pubmed/36075909 http://dx.doi.org/10.1038/s41392-022-01128-2 |
| work_keys_str_mv | AT nishuaishuai prosenescenceneddylationinhibitorcombinedwithasenescenceactivatedbgalactosidaseprodrugtoselectivelytargetcancercells AT liuqian prosenescenceneddylationinhibitorcombinedwithasenescenceactivatedbgalactosidaseprodrugtoselectivelytargetcancercells AT chenxin prosenescenceneddylationinhibitorcombinedwithasenescenceactivatedbgalactosidaseprodrugtoselectivelytargetcancercells AT dinglele prosenescenceneddylationinhibitorcombinedwithasenescenceactivatedbgalactosidaseprodrugtoselectivelytargetcancercells AT cailili prosenescenceneddylationinhibitorcombinedwithasenescenceactivatedbgalactosidaseprodrugtoselectivelytargetcancercells AT maofei prosenescenceneddylationinhibitorcombinedwithasenescenceactivatedbgalactosidaseprodrugtoselectivelytargetcancercells AT shidonglei prosenescenceneddylationinhibitorcombinedwithasenescenceactivatedbgalactosidaseprodrugtoselectivelytargetcancercells AT hoffmanrobertm prosenescenceneddylationinhibitorcombinedwithasenescenceactivatedbgalactosidaseprodrugtoselectivelytargetcancercells AT lijian prosenescenceneddylationinhibitorcombinedwithasenescenceactivatedbgalactosidaseprodrugtoselectivelytargetcancercells AT jialijun prosenescenceneddylationinhibitorcombinedwithasenescenceactivatedbgalactosidaseprodrugtoselectivelytargetcancercells |